Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
80.1M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
39.7M
-
Shares change
-
-2.06M
-
Total reported value, excl. options
-
$468M
-
Value change
-
-$19.4M
-
Put/Call ratio
-
0.57
-
Number of buys
-
92
-
Number of sells
-
-71
-
Price
-
$11.79
Significant Holders of Mind Medicine (MindMed) Inc. - Common Shares (MNMD) as of Q3 2025
229 filings reported holding MNMD - Mind Medicine (MindMed) Inc. - Common Shares as of Q3 2025.
Mind Medicine (MindMed) Inc. - Common Shares (MNMD) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.7M shares
of 80.1M outstanding shares and own 49.61% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (5.94M shares), Commodore Capital LP (3.23M shares), Driehaus Capital Management LLC (3.11M shares), Blackstone Inc. (2.78M shares), MARSHALL WACE, LLP (2.38M shares), Octagon Capital Advisors LP (2.13M shares), VANGUARD GROUP INC (2.01M shares), STATE STREET CORP (1.92M shares), GEODE CAPITAL MANAGEMENT, LLC (1.82M shares), and Deep Track Capital, LP (1.5M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.